Literature DB >> 9836440

A common phosphorylation site for cyclic AMP-dependent protein kinase and protein kinase C in human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

N Okamura1, R Sakakibara.   

Abstract

Human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (HP2K) was phosphorylated by incubation with [gamma-32P]MgATP and cyclic AMP-dependent protein kinase (PKA) or protein kinase C (PKC). Approximately 0.8 mol of phosphate per mol subunit of HP2K was incorporated by either PKA or PKC. However, with additional incubation with PKA following incubation with PKC or vice versa, no additional phosphate was incorporated into the HP2K. The phosphorylation sites for the two protein kinases were identified by peptide mapping and microsequencing following digestion of phosphorylated-HP2K with clostripain. Evidence is also suggested for a common phosphorylation site (Ser-460) for PKA and PKC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836440     DOI: 10.1271/bbb.62.2039

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  10 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Molecular basis of the fructose-2,6-bisphosphatase reaction of PFKFB3: transition state and the C-terminal function.

Authors:  Michael C Cavalier; Song-Gun Kim; David Neau; Yong-Hwan Lee
Journal:  Proteins       Date:  2012-01-31

3.  AICAR enhances the cytotoxicity of PFKFB3 inhibitor in an AMPK signaling-independent manner in colorectal cancer cells.

Authors:  Siyuan Yan; Dongdong Yuan; Qianqian Li; Shi Li; Fan Zhang
Journal:  Med Oncol       Date:  2021-11-10       Impact factor: 3.064

Review 4.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

5.  p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway.

Authors:  Derek A Franklin; Yizhou He; Patrick L Leslie; Andrey P Tikunov; Nick Fenger; Jeffrey M Macdonald; Yanping Zhang
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

Review 6.  Roles of PFKFB3 in cancer.

Authors:  Linlin Shi; Hongming Pan; Zhen Liu; Jiansheng Xie; Weidong Han
Journal:  Signal Transduct Target Ther       Date:  2017-11-24

Review 7.  Fructose 2,6-Bisphosphate in Cancer Cell Metabolism.

Authors:  Ramon Bartrons; Helga Simon-Molas; Ana Rodríguez-García; Esther Castaño; Àurea Navarro-Sabaté; Anna Manzano; Ubaldo E Martinez-Outschoorn
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

8.  Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates.

Authors:  Miao Liu; Nan Li; Chun Qu; Yilin Gao; Lijie Wu; Liangbiao George Hu
Journal:  Commun Biol       Date:  2021-02-12

Review 9.  Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors.

Authors:  Reinier Alvarez; Debjani Mandal; Prashant Chittiboina
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

10.  Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism.

Authors:  Susana Ros; Almut Schulze
Journal:  Cancer Metab       Date:  2013-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.